Skip to main content
. Author manuscript; available in PMC: 2020 Jul 15.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2019 Mar 2;104(4):790–797. doi: 10.1016/j.ijrobp.2019.02.045

Figure 2: Cumulative Incidence of Biochemical and/or Clinical Failure for Low-, Intermediate-, and High-Risk Patients Treated to 70 Gy vs. 78 Gy.

Figure 2:

Sub-group analysis demonstrated no difference in the cumulative incidence of biochemical and/or clinical failure in patients with low risk (Fine-Gray P=0.064), intermediate risk (Fine-Gray P=0.344) and high risk (Fine-Gray P=0.223) disease per the National Comprehensive Cancer Network risk stratification criteria.